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Background: The relationship between maternal hemoglobin (Hb) levels during pregnancy and birth outcomes has
been controversial. Changes in Hb level during pregnancy may have an impact on birth outcomes. This study aimed to
investigate whether changes in Hb levels from early to mid- or late pregnancy is associated with birth outcomes.
Methods: Participants were singleton mothers who delivered at the National Center for Child Health and
Development between 34 and 41 weeks of gestation in 2010 and 2011 (n = 1,986). Hb levels were measured at three
time points: early (<16 weeks), mid- (16–27 weeks), and late (28–36 weeks) pregnancy. Associations between changes
in Hb levels from early to mid- or late pregnancy and birth outcomes (birth weight, Z-score of birth weight, placental
weight, and placental ratio) were assessed by multiple regression, adjusting for maternal and fetal covariates.
Results: A smaller reduction in Hb levels from early to mid- or late pregnancy was significantly associated with
lower birth weight, Z-score of birth weight, placental weight, and placental ratio. Compared to women with an
intermediate reduction from early to late pregnancy, women with the least reduction had a significantly increased
risk of delivering low birth weight (LBW) (adjusted odds ratio [aOR], 2.0; 95% confidence interval [CI], 1.3-3.1) and
small-for-gestational-age (SGA) (aOR, 1.6; 95% CI, 1.04-2.3) infants, while women with the greatest reduction had
a significantly decreased risk of delivering SGA (aOR, 0.38; 95% CI, 0.23-0.65) infants, but an increased risk of high
placental ratio (aOR, 1.7; 95% CI, 1.2-2.5).
Conclusions: Hb changes from early to mid- or late pregnancy were inversely associated with birth weight,
placental weight, and placental ratio.
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The relationship between maternal hemoglobin (Hb)
levels during pregnancy and adverse birth outcomes has
been a source of controversy. Several studies have re-
ported that severe anemia during “early” pregnancy is as-
sociated with adverse birth outcomes, such as low birth
weight (LBW) [1-4], although other studies have showed
no such association [5-8]. It has also been reported that
Hb levels at “mid- or late” pregnancy are inversely associ-
ated with birth weight and placental weight [3,6,9,10]. This
suggests that the association between Hb levels during
pregnancy and birth outcomes may differ based on the
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unless otherwise stated.Physiologically, plasma volume increases by 10 to 15
percent at 6 to 12 weeks of gestation and increases rapidly
thereafter until 30 to 34 weeks [11,12]. This induces a
modest decrease in Hb levels during pregnancy. Even in
healthy pregnant women, the lack of an increase in plasma
volume during pregnancy is associated with lower birth
weight and placental weight, and an increased risk of de-
livering a small-for-gestational-age (SGA) infant [12-14].
However, the impact of changes in Hb levels from early to
mid- or late pregnancy on birth outcomes has not been
investigated in detail.
We hypothesized that a reduction in Hb levels from
early pregnancy to mid- or late pregnancy is a proxy for
plasma volume increase during pregnancy and thus pro-
tects against adverse birth outcomes including LBW, SGA,
and high placental ratio. Thus, the current study aims to
investigate the impact of changes in Hb levels from early tois is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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weight, placental weight, and placental ratio.Methods
Study design and sample population
This is a secondary analysis using records from a hospital
electronic health record system of mothers who delivered
at the National Center for Child Health and Development
(NCCHD, Tokyo, Japan) between January 2010 and
December 2011. We used information collected for rou-
tine antenatal care. Written informed consent for data use
is obtained from patients routinely at the first antenatal
visit. The institutional review board at the NCCHD ap-
proved this study (institutional review board approval no.
34). Expected delivery dates (i.e., gestational age) were
routinely confirmed by an obstetrician via ultrasound.
Inclusion criteria were: 1) singleton pregnancy, 2) Hb mea-
sured at <16 weeks of gestation, and 3) participants who de-
livered at the NCCHD between 34 and 41 weeks of gestation.
We excluded early preterm births (i.e., <34 weeks of gesta-
tion) because these cases mostly lacked Hb measurements
in late pregnancy. We also excluded subjects with pre-
pregnancy diabetes mellitus (DM), gestational diabetes
mellitus (GDM), placenta previa, and fetal anomalies.
We did not exclude cases with hemoglobinopathy, including
the thalassemia trait, since prevalence of hemoglobinopathy
in Japan is quite low ranging from 1 per 2,500 to 1 per
4,000 [15]. A participant flow chart is shown in Figure 1.
A total of 3,169 women delivered at the NCCHD during
the study period. Of these, the following were excluded:
328 twin births, 9 triplet births, 14 with missing informa-
tion for multiple births, 11 with pre-pregnancy DM, 91
with GDM, 50 with placenta previa, and 200 with fetal
anomalies. In addition, 121 deliveries before 34 weeks of
gestation, 2 post-term deliveries, 354 with missing Hb
values at early pregnancy, 1 with missing birth weight, and
2 with missing placental weight were excluded. Thus, a
total of 1,986 pregnancies were included in the analysis.Hb measurements
Three Hb measurements were performed for routine ante-
natal care. The first sample was collected before 16 weeks
of gestation (early Hb), the second between 16 weeks
0 days and 27 weeks 6 days gestation (mid-Hb), and the
third after 28 weeks 0 days gestation (late Hb). Hb levels
were measured with a calibrated laboratory machine
(ADVIA 2120 hematology system, SIEMENS health care)
immediately after blood sample collection. Anemia was
defined as Hb <11.0 g/dL, according to the World Health
Organization definition [16]. Hb changes from early to
mid- or late pregnancy (ΔHbs) were calculated as mid-Hb
minus early Hb, and late Hb minus early Hb, respectively,
and stratified by tertiles based on the sample distribution.Birth outcomes
Primary outcomes were birth weight, Z-score of birth
weight, placental weight, and placental ratio. The placental
ratio was calculated as placental weight (g) divided by
birth weight (g). The Z-score of birth weight was calcu-
lated from the Japanese national reference for birth weight
[17]. For further analysis, continuous outcomes were di-
chotomized as follows: LBW, SGA, and high placental ra-
tio. LBW was defined as being below 2,500 g and SGA
was defined as being below the 10th percentile of the na-
tional reference. High placental ratio was defined as a pla-
cental ratio above the 90th percentile of the sample.
Following deliveries (both vaginal and cesarean section),
the umbilical cord was clamped and cut about 7–8 cm
from the side of the infant. After removing clots, the un-
trimmed placenta and umbilical cord were weighed by
midwives and recorded in electronic format. Although the
use of the untrimmed placenta and umbilical cord may
introduce some bias into the placental weight measure-
ments, we considered this method consistent with another
study and believe any effects would be negated by the large
sample size [18]. Placental weight did not differ by delivery
method. The weights of all infants were measured immedi-
ately after delivery upon completion of a physical examin-
ation. Pregnancy complications and delivery summaries
were also recorded in electronic format by obstetricians.
Covariates
Information on participant age, pre-pregnancy body weight,
height, parity, artificial reproductive technology (ART) for
conception, past medical complications (i.e., hypertension,
autoimmune disease, Basedow’s disease (i.e. hyperthyroid-
ism), and hypothyroid disease), and smoking and drinking
status were collected by questionnaire at the time of the
first antenatal visit and recorded in the NCCHD medical
database. Pre-pregnancy BMI was calculated as weight
[kg]/height2 [m]. Data regarding iron prescriptions, blood
pressure (BP) before 16 weeks of gestation, and body
weight at the last antenatal visit were also retrieved from
the database. Participant weight gain during pregnancy
was calculated as body weight at the last antenatal visit
[kg] before delivery minus pre-pregnancy body weight
[kg]. BP measured before 16 weeks of gestation at the
antenatal visit was converted into mean arterial pressure
(MAP) as follows: MAP = (2*diastolic BP + systolic BP)/3.
Fetal sex was also retrieved from the delivery summary.
Statistical analysis
To evaluate the direct effect of Hb levels at different ges-
tational ages and Hb changes from early pregnancy on
birth weight, Z-score of birth weight, placental weight,
and placental ratio, we conducted multiple linear regres-
sion analysis, adjusting for maternal and fetal covariates.
We first analyzed the association between Hb levels at
Figure 1 Participant flow chart.
Jwa et al. BMC Pregnancy and Childbirth  (2015) 15:80 Page 3 of 10early, mid-, and late pregnancy and birth outcomes with-
out adjustment, and defined this as the crude model.
We then adjusted for potential confounders including
maternal age, parity, pre-pregnancy BMI, smoking sta-
tus, ART, and fetal sex, and defined this as Model 1. We
further adjusted for MAP at early pregnancy and past
medical complications (i.e., hypertension, autoimmune
disease, Basedow’s disease, and hypothyroid disease), and
defined this as Model 2. As with the analysis of Hb levels
and birth outcomes, we evaluated the association be-
tween Hb changes from early to mid- or late pregnancy
and birth outcomes by replacing Hb levels with Hb
changes from early pregnancy in the previous models.
We also added Hb levels at early pregnancy to Model 2
and defined this as Model 3 in order to evaluate the in-
dependent effect of changes of Hb levels from early
pregnancy on birth outcomes. The placental ratio was
multiplied by 1000 for regression analysis since the co-
efficient of each independent variable was too small. Fi-
nally, we evaluated risks of LBW, SGA, and high placental
ratio according to tertiles of changes in Hb levels from
early to mid- or late pregnancy by multiple logistic regres-
sion analysis. Trends across tertiles of changes in Hb levels
from early pregnancy were tested by treating the level of
exposure as an ordinal variable in the logistic model.Since there were missing values for mid- (5.4%) and
late (0.8%) Hb and several other covariates from 1.2% in
pre-pregnancy BMI to 9.6% in MAP, multiple imputation
was performed. Model-wise deletion was also performed
as sensitivity analysis and the results did not change.
P < 0.05 was considered statistically significant. All ana-
lyses were performed with Stata SE software (Version
12; Stata Corporation, College Station, TX).
Results
Baseline characteristics of the sample population stratified
by tertiles of Hb changes from early to late pregnancy are
shown in Table 1. The mean maternal age was 35.5 years
(standard deviation [SD] = 4.2), 53% of participants were
nulliparous, and 16% used ART for conception. Women
who were classified as having the least reduction from
early to late pregnancy (i.e. –1.0 ≤Hb change [g/dL]) were
more likely to be nulliparous, and had lower pre-
pregnancy BMI and MAP at early pregnancy.
Hb levels during pregnancy and birth outcomes strati-
fied by tertiles of Hb changes from early to late pregnancy
are shown in Table 2. Mean gestational ages at the time of
Hb measurements (weeks) were 11.4 (SD = 2.0) at early
pregnancy, 24.7 (SD = 1.5) at mid-pregnancy and 35.4
(SD= 1.3) at late pregnancy. Mean Hb levels were 12.5 g/dL
Table 1 Baseline characteristics at early pregnancy stratified by tertiles of Hb changes from early to late pregnancy
(n = 1986)a, b
Characteristics Total (n = 1986) Greatest reduction
(Hb change < −1.9)
(n = 639)
Intermediate reduction
(−1.9 ≤Hb change < −1.0)
(n = 689)
Least reduction
(Hb change ≥ −1.0)
(n = 658)
Maternal age, (years) 35.5 (4.2) 35.6 (4.1) 35.4 (4.2) 35.4 (4.4)
Pre-pregnancy BMI, (kg/m2) 20.3 (2.6) 20.5 (2.7) 20.3 (2.5) 20.0 (2.6)
Maternal weight gain until delivery, (kg) 9.6 (3.4) 9.5 (3.4) 9.7 (3.5) 9.6 (3.2)
Parity
0, n (%) 1057 (53.2) 296 (46.3) 373 (54.1) 388 (59.0)
1, n (%) 730 (36.8) 273 (42.7) 251 (36.4) 206 (31.3)
≥2, n (%) 199 (10.0) 70 (11.0) 65 (9.4) 64 (9.7)
ART, n (%) 310 (15.6) 101 (15.8) 108 (15.7) 101 (15.3)
Maternal pre-pregnancy complications
Hypertension, n (%) 25 (1.3) 11 (1.7) 9 (1.3) 5 (0.76)
Autoimmune disease, n (%) 44 (2.2) 14 (2.2) 15 (2.2) 15 (2.3)
Basedow’s disease, n (%) 28 (1.4) 10 (1.6) 13 (1.9) 5 (0.76)
Hypothyroid, n (%) 51 (2.6) 13 (2.0) 22 (3.2) 16 (2.4)
Smoking
Never or former, n (%) 1981 (99.7) 638 (99.8) 688 (99.9) 655 (99.5)
Current, n (%) 5 (0.25) 1 (0.16) 1 (0.15) 3 (0.46)
Alcohol intake
Current, n (%) 158 (8.0) 48 (7.5) 58 (8.4) 52 (7.9)
MAP at early pregnancy, (mmHg)c 79.5 (9.6) 80.8 (9.7) 79.5 (9.6) 78.2 (9.4)
aValues are presented as mean (SD) for continuous variables and n (%) for dichotomous variables.
bHb tertiles were calculated from the distribution of Hb changes from early to late pregnancy (i.e., Hb at late pregnancy - Hb at early pregnancy).
cCalculated as (2 x diastolic BP + systolic BP)/3.
ART, artificial reproductive technology; MAP, mean arterial pressure; SD, standard deviation.
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mid-pregnancy and 11.1 g/dL (SD = 1.0) at late preg-
nancy. Ninety-one participants (4.5%) were anemic at
early pregnancy, and this dramatically increased to 876
(44.1%) in mid-pregnancy and 907 (45.7%) in late preg-
nancy. Women with the least reduction from early to
late pregnancy were more likely to be anemic during
early pregnancy, but less likely during late pregnancy.
Iron supplementation was prescribed more often to
women with the least reduction at mid-pregnancy, but
less likely in late pregnancy.
Mean gestational age at delivery was 39.1 weeks (SD =
1.3). In the study population, 1,205 women (60.7%)
underwent vaginal deliveries, 297 women (15.0%) had
forceps or vacuum deliveries, and 484 women (24.4%)
had Cesarean deliveries. Women with the greatest re-
duction from early to late pregnancy had a higher rate of
Cesarean deliveries (27.4%) compared with women with
the least reduction (22.3%). Mean birth weight was
3,016 g (SD = 370), mean placental weight was 546 g
(SD = 101), and mean placental ratio was 0.18 (SD =
0.027). There were 132 (6.2%) LBW and 139 (7.0%) SGA
infants. Women with the least reduction from early tolate pregnancy tended to have a lower birth weight,
Z-score of birth weight, and placental weight, resulting
in a higher proportion of LBW and SGA infants com-
pared with women in the intermediate or greatest reduc-
tion groups.
The results of multiple regression analysis for the asso-
ciation between Hb levels at early, mid-, or late preg-
nancy and birth outcomes are shown in Table 3. Hb
levels at early pregnancy were not significantly associ-
ated with birth weight, Z-score of birth weight, placental
weight, and placental ratio, whereas Hb levels at mid-
and late pregnancy were significantly inversely associated
with these outcomes. This suggests that if Hb levels
increased +1 g/dL at mid- or late pregnancy, birth
weight changed by −57.9 g (95% CI, −77.3 to −38.5)
and −73.2 g (95% CI, −90.0 to −56.4), respectively, in the
adjusted model. Similar significant inverse associations
were observed for Z-score of birth weight, placental
weight, and placental ratio.
The effects of Hb changes from early pregnancy to
mid- or late pregnancy on birth outcomes are shown in
Table 4. Hb changes from early to mid- or late preg-
nancy were significantly inversely associated with birth
Table 2 Hb levels at early, mid-, and late pregnancy and birth outcomes stratified by tertiles of Hb changes from early
to late pregnancy (n = 1986)a, b
Variable Total (n = 1986) Greatest reduction
(Hb change < −1.9)
(n = 639)
Intermediate reduction
(−1.9 ≤Hb change < −1.0)
(n = 689)
Least reduction
(Hb change ≥ −1.0)
(n = 658)
Early pregnancy (<16 weeks)
Hb, (g/dL) 12.5 (0.88) 13.0 (0.73) 12.5 (0.75) 12.0 (0.87)
Anemia (<11 g/dL), n (%) 89 (4.5) 4 (0.63) 14 (2.0) 70 (10.6)
Gestational age at measurement, (weeks) 11.4 (2.0) 11.0 (1.9) 11.4 (1.9) 11.7 (2.0)
Iron supplement intake 12 (0.60) 0 (0) 1 (0.15) 11 (1.7)
Mid-pregnancy (16–27 weeks)
Hb, (g/dL) 11.0 (0.86) 11.1 (0.79) 11.1 (0.83) 11.0 (0.95)
Anemia (<11 g/dL), n (%) 876 (44.1) 276 (43.2) 288 (41.8) 312 (47.4)
Gestational age at measurement, (weeks) 24.7 (1.5) 24.6 (1.5) 24.7 (1.6) 24.8 (1.5)
Iron supplement intake 290 (14.6) 59 (9.2) 79 (11.5) 152 (23.1)
Late pregnancy (28–37 weeks)
Hb, (g/dL) 11.1 (0.96) 10.4 (0.79) 11.0 (0.77) 11.7 (0.84)
Anemia (<11 g/dL), n (%) 907 (45.7) 473 (74.0) 316 (45.9) 118 (17.9)
Gestational age at measurement, (weeks) 35.4 (1.3) 35.3 (1.4) 35.4 (1.3) 35.5 (1.2)
Iron supplement intake 408 (20.5) 228 (35.7) 102 (14.8) 78 (11.9)
Pregnancy complication
Pregnancy-induced hypertension, n (%) 44 (2.2) 15 (2.3) 14 (2.0) 15 (2.3)
Delivery outcomes
Gestational age of delivery, (week) 39.1 (1.3) 39.1 (1.3) 39.3 (1.2) 39.3 (1.3)
Preterm birth, n (%) 68 (3.4) 24 (3.8) 22 (3.2) 22 (3.3)
Mode of delivery
Normal vaginal delivery, n (%) 1205 (60.7) 367 (57.4) 422 (61.2) 416 (63.2)
Forceps or vacuum delivery, n (%) 297 (15.0) 97 (15.2) 105 (15.2) 95 (14.4)
Cesarean section, n (%) 484 (24.4) 175 (27.4) 162 (23.5) 147 (22.3)
Sex (male), n (%) 1029 (51.8) 322 (50.4) 363 (52.7) 344 (52.3)
Birth weight, (g) 3016 (370) 3068 (354) 3032 (369) 2947 (386)
Z-score of birth weight 0.078 (0.94) 0.27 (0.89) 0.096 (0.93) −0.13 (0.95)
Low birth weight, n (%) 132 (6.6) 32 (5.0) 38 (5.5) 62 (9.4)
Small for gestational age, n (%)c 139 (7.0) 22 (3.4) 51 (7.4) 66 (10.0)
Placental weight, (g) 546 (101) 572 (101) 545 (100) 523 (98)
Placental ratio 0.18 (0.027) 0.19 (0.029) 0.18 (0.026) 0.18 (0.026)
High placental ratio, n (%)d 192 (9.7) 87(13.6) 60 (8.7) 45 (6.8)
aValues are presented as mean (SD) for continuous variables and n (%) for dichotomous variables.
bHb tertiles were calculated from the distribution of Hb changes from early to late pregnancy (i.e., Hb at late pregnancy - Hb at early pregnancy).
cSGA is defined as being below the 10th percentile of the Japanese national reference.
dHigh placental ratio is defined as being over the 90th percentile of the sample population.
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placental ratio, after adjusting for confounders and
Hb levels in early pregnancy. The results indicate that
a +1 g increase in Hb from early to late pregnancy was
associated with a −76.1 (95% CI, −94.0 to −58.2) change
in birth weight (g), a −0.21 (95% CI, −0.26 to −0.17)
change in Z-score of birth weight, a −26.1 (95%
CI, −30.9 to −21.2) change in placental weight (g), anda −4.0 (95% CI, −5.4 to −2.7) change in placental ratio
(x1000), in the adjusted model.
Results of logistic regression of Hb changes from early
to mid- or late pregnancy for the outcomes of LBW,
SGA, and high placental ratio are shown in Table 5.
Women with the least reduction from early to mid-
pregnancy (i.e. –1.0 ≤Hb change) had a significantly in-
creased risk of delivering SGA infants (adjusted OR
Table 3 Association between Hb levels at early, mid-, and late pregnancy and birth outcomes (n = 1986)
Birth outcome Hb levels
during
pregnancy
Crude model Model 1 Model 2
Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI
Birth weight (g) Early pregnancy −13.6 −32.0 to 4.8 −25.1* −43.5 to −6.7 −18.1 −36.8 to 0.49
Mid-pregnancy −55.3** −74.7 to −35.9 −63.4** −82.6 to −44.2 −57.9** −77.3 to −38.5
Late pregnancy −71.0** −88.0 to −53.9 −75.9** −92.8 to −59.1 −73.2** −90.0 to −56.4
Z-score of birth weight Early pregnancy −0.0035 −0.050 to 0.043 −0.039 −0.086 to 0.0074 −0.028 −0.076 to 0.019
Mid-pregnancy −0.14** −0.19 to −0.088 −0.16** −0.21 to −0.11 −0.15** −0.20 to −0.10
Late pregnancy −0.19** −0.23 to −0.14 −0.20** −0.24 to −0.16 −0.20** −0.24 to −0.16
Placental weight (g) Early pregnancy 2.1 −2.9 to 7.1 −1.0 −6.1 to 4.0 −0.55 −5.7 to 4.6
Mid-pregnancy −15.5** −20.8 to −10.2 −17.7** −23.0 to −12.4 −17.6** −23.0 to −12.3
Late pregnancy −22.4** −27.0 to −17.9 −23.3** −27.9 to −18.7 −23.3** −27.9 to −18.8
Placental ratio (x1000) Early pregnancy 1.55* 0.20 to 2.9 1.2 −0.18 to 2.5 0.91 −0.48 to 2.3
Mid-pregnancy −1.8* −3.2 to −0.35 −2.1* −3.5 to −0.63 −2.4* −3.9 to −0.93
Late pregnancy −3.1** −4.4 to −1.9 −3.1** −4.4 to −1.9 −3.3** −4.6 to −2.0
*P < 0.05, **P < 0.001.
Model 1: adjusted for maternal age, parity, pre-pregnancy BMI, smoking, ART, fetal sex.
Model 2: adjusted for Model 1 + MAP at early pregnancy and medical complications (hypertension, autoimmune disease, Basedow’s disease, hypothyroid disease).
ART, artificial reproductive technology; CI, confidence interval; Hb, Hemoglobin; MAP, mean arterial pressure; Z-score, z-score of birth weight.
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having a high placental ratio (aOR, 0.59; 95% CI, 0.39 to
0.90), compared with women with an intermediate re-
duction (i.e. –1.9 ≤Hb change < −1.0). With respect to
the analysis of Hb changes from early to late pregnancy,
compared with women with an intermediate reduction,
women with the least reduction had a significantly in-
creased risk of delivering a LBW (aOR, 2.0; 95% CI, 1.3
to 3.1) or SGA (aOR, 1.6; 95% CI, 1.04 to 2.3) infant. On
the other hand, women with the greatest reduction (i.e.
Hb change < −1.9) had a significantly reduced risk of de-
livering a SGA (aOR, 0.38; 95% CI, 0.23 to 0.65) infant,
and an increased risk of high placental ratio (aOR, 1.7;
95% CI, 1.2 to 2.5). This resulted in a significant linear
trend between Hb tertiles from early to late pregnancy,
and risks of LBW, SGA, and high placental ratio (p value
for trend <0.001).
Discussion
In this study, we found that changes of Hb levels from
early pregnancy were significantly inversely associated
with birth weight, Z-score of birth weight, placental
weight, and placental ratio in pregnant Japanese women.
Women with the least reduction from early to late preg-
nancy had a significantly increased risk of delivering a
LBW or SGA infant and a decreased risk of high placen-
tal ratio, compared to women with the intermediate or
greatest reduction.
Although some studies have assessed the association
of Hb levels at early [6,5,8,19,20], mid- [6,19,21,22], and
late pregnancy [21,23,24], or minimum Hb levels during
pregnancy [12,19,25], with LBW, SGA, and placentalratio, only a few studies have reported on the association
between Hb changes during pregnancy and these birth
outcomes [4,10,12]. Whittaker et al. studied serial
hematologic changes, including Hb and plasma volume,
throughout pregnancy in 69 women in the United King-
dom and reported no significant association between Hb
changes from pre-pregnancy to late pregnancy and birth
weight or placental weight, although Hb changes were
negatively correlated with birth weight and placental
weight [12]. However, their small sample size may not
have had sufficient statistical power to detect the associ-
ation between Hb changes and birth outcomes.
Bakacak et al. also investigated Hb levels at different
trimesters in 329 pregnant Turkish women without ma-
ternal complications [4]. They demonstrated that women
who delivered LBW infants had a smaller Hb reduction
(ΔHb = −0.6, SD = 2.9) from early to late pregnancy
compared with women who delivered babies weighing
more than 3500 g (ΔHb = −1.5, SD = 3.6); however,
the relationship did not reach a statistically significant
level (P value = 0.06). Gonzales et al. also found that
pregnant Peruvian women who were initially nonanemic
(11–14.5 g/dL) at first booking and who later showed in-
creased Hb (>14.5 g/dL) due to erythrocytosis in a sec-
ond Hb measurement had a significant increased risk for
SGA (aOR 1.66; 95% CI, 1.51 to 1.83) [10]. In our study,
mothers with Hb values of more than 13.3 or 15.5 g/dL
at late pregnancy were prone to have SGA or LBW in-
fants respectively, regardless of iron supplementation
(data not shown). Thus, women with Hb values in this
range or higher should be closely monitored during
pregnancy. In addition to those previous findings, we
Table 4 Association between Hb changes (ΔHb) from early to mid- or late pregnancy and birth outcomes (n = 1986)
Birth outcome Hb changes from
early pregnancy
Crude model Model 1 Model 2 Model 3
Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI
Birth weight (g) ΔHb (mid-Hb – early Hb) −51.0** −72.9 to −29.1 −45.2** −67.0 to −23.4 −46.9** −68.5 to −25.2 −73.5** −98.0 to −48.9
ΔHb (late Hb – early Hb) −48.8** −64.4 to −33.3 −45.0** −60.4 to −29.5 −47.8** −63.1 to −32.4 −76.1** −94.0 to −58.2
Z-score of birth weight ΔHb (mid-Hb – early Hb) −0.17** −0.22 to −0.11 −0.15** −0.20 to −0.093 −0.15** −0.21 to −0.096 −0.21** −0.28 to −0.15
ΔHb (late Hb – early Hb) −0.15** −0.19 to −0.11 −0.14** −0.18 to −0.10 −0.14** −0.18 to −0.11 −0.21** −0.26 to −0.17
Placental weight (g) ΔHb (mid-Hb – early Hb) −22.5** −28.4 to −16.5 −20.7** −26.7 to −14.8 −20.8** −26.7 to −14.9 −27.3** −34.0 to −20.6
ΔHb (late Hb – early Hb) −20.0** −24.2 to −15.8 −18.4** −22.6 to −14.3 −18.8** −22.9 to −14.6 −26.1** −30.9 to −21.2
Placental ratio (x1000) ΔHb (mid-Hb – early Hb) −4.4** −6.0 to −2.8 −4.2** −5.8 to −2.6 −4.1** −5.7 to −2.5 −4.7** −6.5 to −2.8
ΔHb (late Hb – early Hb) −3.7** −4.8 to −2.6 −3.4** −4.5 to −2.2 −3.3** −4.5 to −2.2 −4.0** −5.4 to −2.7
**P < 0.001.
Model 1: adjusted for maternal age, parity, pre-pregnancy BMI, smoking, ART, fetal sex.
Model 2: adjusted for Model 1 + MAP at early pregnancy and medical complications (hypertension, autoimmune disease, Basedow’s disease, hypothyroid disease).
Model 3: adjusted for Model 3 + Hb levels at early pregnancy.














Table 5 Adjusted OR and 95% CI of Hb changes from early pregnancy for low birth weight, small for gestational age,
and high placental ratioa
LBW SGAb High placental ratioc
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Hb changes from early to mid-pregnancyd
Greatest reduction (Hb change < −1.7) (n = 675) 1.2 (0.74 to 1.9) 0.72 (0.44 to 1.2) 1.1 (0.74 to 1.5)
Intermediate reduction (−1.7≤ Hb change < −1.1) (n = 680) Reference Reference Reference
Least reduction (Hb change≥ −1.1) (n = 631) 1.3 (0.84 to 2.1) 1.6 (1.1 to 2.5) 0.59 (0.39 to 0.90)
P for trend 0.66 0.001 0.02
Hb changes from early to late pregnancyd
Greatest reduction (Hb change < −1.9) (n = 639) 0.77 (0.46 to 1.3) 0.38 (0.23 to 0.65) 1.7 (1.2 to 2.5)
Intermediate reduction (−1.9≤ Hb change < −1.0) (n = 689) Reference Reference Reference
Least reduction (Hb change≥ −1.0) (n = 658) 2.0 (1.3 to 3.1) 1.6 (1.04 to 2.3) 0.76 (0.49 to 1.2)
P for trend <0.001 <0.001 <0.001
aAdjusted for maternal age, parity, pre-pregnancy BMI, smoking, ART, fetal sex, MAP at early pregnancy, medical complications (hypertension, autoimmune disease,
Basedow’s disease, hypothyroid disease), and Hb levels at early pregnancy.
bSGA is defined as being below the 10th percentile of the Japanese national reference.
cHigh placental ratio is defined as being over the 90th percentile of the sample population.
dHb changes were calculated as Hb at mid- or late pregnancy – Hb at early pregnancy.
ART, artificial reproductive technology; CI, confidence interval; Hb, hemoglobin; LBW, low birth weight; MAP, mean arterial pressure; OR, odds ratio; SGA, small for
gestational age.
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changes in Hb during pregnancy and birth weight in a
Japanese population, and further found inverse associa-
tions between changes in Hb during pregnancy with pla-
cental weight, and placental ratio.
One potential explanation for the association between a
reduction in Hb levels from early pregnancy and a larger
birth weight is that Hb changes during pregnancy may re-
flect plasma volume expansion. A smaller reduction in Hb
levels from early pregnancy may suggest a failure to ex-
pand plasma volume during pregnancy, which may impair
fetoplacental circulation [26]. Whittaker et al. reported
that changes in Hb levels from pre-pregnancy to late preg-
nancy were significantly correlated with changes in plasma
volume [12], and reduced plasma volume expansion dur-
ing pregnancy reportedly increases the risk of smaller
birth weight and SGA [12,13].
We also found that Hb changes were significantly in-
versely associated with placental ratio, which may ex-
plain conflicting results from previous studies regarding
anemia during pregnancy and the increased risk of high
placental ratio. While one study found no association
between Hb levels at the first antenatal visit and placen-
tal ratio [5], other studies have reported that Hb at later
gestational ages, including the lowest level of Hb during
pregnancy, were inversely associated with placental ratio
[21,27,28]. Our findings suggest that changes in Hb
levels from early to mid- or late pregnancy may have an
independent effect on placental ratio regardless of Hb
levels at early pregnancy, with a larger reduction in Hb
levels from early pregnancy resulting in lower Hb levels
at mid- or late pregnancy and an increased risk of highplacental ratio. Given the increase in the number of re-
ports suggesting an association between high placental
ratios and adverse short- and long-term health outcomes
[25,29-33], larger changes in Hb levels from early preg-
nancy may not necessarily reflect a favorable intrauterine
environment.
This study has several limitations. First, the study was
conducted in a single perinatal center where pregnant
women with complications tend to deliver. The mean
maternal age was higher than that of the general popula-
tion in Japan (our study vs. general population, 35.5 vs.
30) [34]. Also, the proportion of women who conceived
via ART was relatively high (16%). Thus, caution should
be exercised when generalizing our results. However,
routine antenatal care including the timing of Hb meas-
urement during pregnancy and obstetric intervention
such as the decision to terminate the pregnancy was
consistent as the study was based at a single institution,
and so differential measurement errors are less likely to
have been introduced. Since delivery records were input-
ted directly by obstetricians to prevent misclassification
in the database, critical misclassification is also less
likely. Second, we did not evaluate the effect of iron in-
take during pregnancy. Hb changes from early preg-
nancy may, in part, be mediated by iron intake during
pregnancy, including iron supplementation. Iron intake
during pregnancy could account for a smaller reduction
in Hb. However, we did not collect data regarding iron
intake other than prescription information, and data on
adherence to prescribed iron supplements and other
non-prescribed iron supplements were not available for
this study. Thus, randomized controlled trials of iron
Jwa et al. BMC Pregnancy and Childbirth  (2015) 15:80 Page 9 of 10supplements are needed to evaluate the exact effect of
iron supplements on Hb changes during pregnancy and
on birth outcomes. Interestingly, two randomized con-
trolled trials of routine prenatal iron supplement intake in
initially non-anemic women from early to mid-pregnancy
in the United States did not alter third trimester Hb levels,
but significantly increased birth weight compared with the
placebo group [35,36]. Thus, it is less likely that iron in-
take during pregnancy could cause a lower birth weight
via a smaller reduction in Hb during pregnancy.
Conclusions
Changes in Hb levels from early pregnancy were signifi-
cantly inversely associated with birth weight, placental
weight, and placental ratio. Although the underlying
mechanisms are unknown, these results suggest that, in
addition to Hb levels alone, changes in Hb levels from
early pregnancy may impact birth outcomes. Given the
findings of our study, further studies are needed to
evaluate changes in Hb levels together with plasma vol-
ume during pregnancy and on birth outcomes in a more
diverse population, with additional information on co-
morbidities and iron supplementation during pregnancy.
Importantly, our study suggests that clinicians may also
consider changes in Hb levels in antenatal care in
addition to Hb levels at a specific point in pregnancy.
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